Single Patient Multiple Cross-Over Trials To Determine The Efficacy Of Pilocarpine In Relieving Dry Mouth In Patients With Cancer
University of Queensland
70 participants
Nov 1, 2010
Interventional
Conditions
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Active pilocarpine 4% (40 mg/ml) drops; Pilcoarpine (po) 2-3 drops 3 times daily (4-6 mg three times daily) with meals in raspberry water delivered as a mouth dropper. Rasberry water is combined with the active treatment in order to simulate the taste of the placebo, rasberry water. This is to ensure the patient remains blind to the treatment. The active treatment will be administered in a cycle pair. A cycle pair is a course of treatment over 6 days. For 3 consecutive days, the patient will take the active treatment followed by 3 days on placebo. The duration of the trial will consist of 3 cycle pairs taking place over 18 days. A follow-up on day 19 by the patients physician will then take place. A washout period will be instigated on the first day of each cycle. On that day, no measurements will be taken.
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12610000840088